Sarraf Gentile

We are happy to commend the U.S. Department of Justice for responding so quickly – in a matter of days! – to address misconduct related to the coronavirus / COVID-19 pandemic. On Friday, March 20, Attorney General Barr issued a statement noting the Department’s concerns regarding Covid-19 related frauds and calling on the public to […]

[This article first appeared on Cafepharma, written by Joseph Gentile.] With the passage of sweeping legislation that will pump hundreds of billions (possibly over a trillion+) dollars into the economy to combat the Coronavirus and mitigate its effect, the stage has been set for rampant fraud. And there’s no doubt that the ensuing attempts at […]

With the passage of sweeping legislation that will introduce enormous amounts of money into the economy to combat the Coronavirus and mitigate its effect, we have written a letter to Attorney General Barr urging him to take pre-emptive action and launch an initiative to combat any fraud in the government’s new Coronavirus programs. The role […]

The world is in a crisis. Our local communities are either in the midst of a crisis or on the cusp of one. The medical system is about to get inundated with the sick and dying. Layoffs and financial difficulties will likely multiply. The coronavirus outbreak is going to impact all of our lives and […]

An interesting article published by Reveal from The Center for Investigative Reporting, dated December 14, 2019, caught our attention.  You can view the article here. The article discusses how senior care-home operators in several states were caught stealing workers’ wages or breaking other labor laws.  And despite violating the law, these operators continue to take […]

We’re proud to announce that we represented one of the whistleblowers in the government’s historic $1.4 billion recovery against Reckitt Benckiser Group PLC. The case, which included multiple filings over several years, involved the marketing of Reckitt’s opioid addiction treatment drug Suboxone – which is used by recovering opioid addicts to avoid or reduce withdrawal […]

The Supreme Court just held that the 10-year statute of limitation period in the federal False Claims Act (FCA) applies to all FCA suits brought by whistleblowers, and further held that a whistleblower is not an “official of the United States” for purposes of limiting the time period for such suits. A copy of the […]

On May 6, 2019, the Justice Department announced new guidelines regarding the manner in which the government will credit a defendant who cooperates in a False Claims Act (FCA) investigation. A defendant charged with defrauding the federal government and violating the FCA, can now earn credit by cooperating with the government’s investigation by engaging in […]

The New York False Claims Act protects the State from being defrauded by encouraging whistleblowers to identify and bring claims on behalf of the State. Modeled after the federal False Claims Act, whistleblowers who bring successful claims on behalf of the State are awarded a percentage of whatever the State recovers. False statements made to […]

The Federal False Claims Act protects U.S. taxpayers from fraud by encouraging whistleblowers to identify and bring qui tam lawsuits on behalf of the federal government against those who seek to defraud the government. Enacted after the Civil War to address unscrupulous merchants who sold the government defective products, the law is designed to ensure […]